1. |
Dahlin M, Prast-Nielsen S. The gut microbiome and epilepsy. E Bio Medicine, 2019, 44(7): 741-746.
|
2. |
Dubey D, Pittock SJ, McKeon A. Antibody prevalence in epilepsy and encephalopathy score: increased specificity and applicability. Epilepsia, 2019, 60(2): 367-369.
|
3. |
Braakman H, van Ingen J. Can epilepsy be treated by antibiotics? J Neurol, 2018, 265(8): 1934-1936.
|
4. |
Hauser RM, Henshall DC, Lubin FD. The epigenetics of epilepsy and its progression. Neuroscientist, 2018, 24(2): 186-200.
|
5. |
卢燕, 刘占利. 肠道菌群和癫痫相关性研究进展. 中华全科医学, 2018, 16(09): 1550-1553.
|
6. |
Lin Z, Si Q, Xiaoyi Z. Association between epilepsy and systemic autoimmune diseases: a meta-analysis. seizure. European Journal of Epilepsy, 2016, 41(10): 160-166.
|
7. |
Dubey D, Singh J, Britton JW, et al. Predictive models in the diagnosis and treatment of autoimmune epilepsy. Epilepsia, 2017, (7): 1181-1189.
|
8. |
Gozubatik-Celik G, Ozkara C, Ulusoy C, et al. Anti-neuronal autoantibodies in both drug responsive and resistant focal seizures with unknown cause. Epilepsy Research, 2017, 135(9): 131-136.
|
9. |
Sukhvir W, Ada TG, Cornelia MJZ, et al. Neuronal antibodies in pediatric epilepsy: clinical features and long-term outcomes of ahistorical cohort not treated with immunotherapy. Epilepsia, 2016, 57(5): 823-831.
|
10. |
Bien CG, Holtkamp M. “Autoimmune Epilepsy”: encephalitis with autoantibodies for epileptologists. Epilepsy Curr, 2017, 17(3): 134-141.
|
11. |
Husari KS, Dubey D. Autoimmune epilepsy. Neurotherapeutics, 2019, 16(3): 685-702.
|
12. |
Frazzini V, Nguyen-Michel VH, Habert MO, et al. Focal status epilepticus in anti-Hu encephalitis. Autoimmun Rev, 2019, 9: 102388.
|
13. |
Navarro V, Kas A, Apartis E, et al. Motor cortex and hippocampus are the two main cortical targets in LGI1-antibody encephalitis. Brain, 2016, 139(Pt 4): 1079-1093.
|
14. |
Lu Y, Wang Y, Wu X, et al. Clinical features and long-term outcomes of seizures associated with autoimmune encephalitis: a follow-up study in East China. Journal of clinical neuroscience, 2019, 68(10): 73-79.
|
15. |
LV R J. Clinical analysis of 42 autoimmune epilepsy patients with autoantibody. China Medical Abstracts(Internal Medicine), 2018, 35(3): 188.
|
16. |
Tecellioglu M, Kamisli O, Kamisli S, et al. Neurological autoantibodies in drug-resistant epilepsy of unknown cause. Ir J Med Sci, 2018, 187(4): 1057-1063.
|
17. |
Tezer F I, Firat A, Tuzun E, et al. Immunopathology in drug resistant mesial temporal lobe epilepsy with different types of hippocampal sclerosis. International Journal of Neuroscience, 2018, (5): 421-428.
|
18. |
de Timary P, Stärkel P, Delzenne NM, et al. A role for the peripheral immune system in the development of alcohol use disorders? Neuropharmacology, 2017, 122(8): 148-160.
|
19. |
Wang H, Wang Y. Gut microbiota-brain axis. Chinese Medical Journal, 2016, 19(1): 2373-2380.
|
20. |
Vezzani A, Fujinami RS, White HS, et al. Infections, inflammation and epilepsy. Acta Neuropathologica, 2016, (2): 211-234.
|
21. |
Rothhammer V, Borucki DM, Tjon EC, et al. Microglial control of astrocytes in response to microbial metabolites. Nature, 2018, 557(7707): 724-728.
|
22. |
Stephenson J, Nutma E, Valk P, et al. Inflammation in CNS neurodegenerative diseases. Immunology, 2018, 154(2): 204-219.
|
23. |
Dubey D, Samudra N, Gupta P, et al. Retrospective case series of the clinical features, management and outcomes of patients with autoimmune epilepsy. Seizure, 2015, 29(7): 143-147.
|
24. |
Wu J, Zhang Y, Yang H, et al. Intestinal microbiota as an alternative therapeutic target for epilepsy. Can J Infect Dis Med Microbiol, 2016, 2016: 9032809.
|
25. |
Toledano M, Britton J W, McKeon A, et al. Utility of an immunotherapy trial in evaluating patients with presumed autoimmune epilepsy. Neurology, 2014, 82(18): 1578-1586.
|
26. |
曾畅, 王冕, 张晨, 等. 自身免疫性癫痫入院诊断与免疫治疗转归的相关性. 中南大学学报(医学版), 2019, 44(8): 885-891.
|
27. |
Seo JH, Lee YJ, Lee KH, et al. Autoimmune encephalitis and epilepsy: evolving definition and clinical spectrum. Korean J Pediatr, 2019, 16(8): 00598.
|
28. |
Hakamifard A, Naghibi SN, Hashemi FS. Anti-NMDA receptor encephalitis presenting with status epilepticus: brucellosis as a possible triggering factor: a case report. Int J Prev Med, 2019, 10(7): 119.
|
29. |
Gaspard N. Putting a band-aid on a broken leg: antiseizure medications are inferior to immune therapies in autoimmune epilepsy. Epilepsy Curr, 2019, 19(5): 302-304.
|